ライフサイエンスコーパス: branched-chain amino acid

1 lycolysis/gluconeogenesis, and metabolism of branched chain amino acids.

2 biosynthetic enzymes for heme, cysteine, and branched chain amino acids.

3 proteins that is responsive to both GTP and branched chain amino acids.

4 olderia pseudomallei that is auxotrophic for branched chain amino acids.

5 ed esters arising from partial catabolism of branched chain amino-acids.

6 nd enhanced levels of volatiles derived from branched-chain amino acids.

7 or activation and for feedback inhibition by branched-chain amino acids.

8 lag in growth when nutritionally limited for branched-chain amino acids.

9 tin, C-reactive protein, acylcarnitines, and branched-chain amino acids.

10 protein, E1alpha phosphorylation, and plasma branched-chain amino acids.

11 anscriptional regulator that is activated by branched-chain amino acids.

12 known as yhdG) that encodes a transporter of branched-chain amino acids.

13 etabolites through its activation by GTP and branched-chain amino acids.

14 ain transporters that accumulate proline and branched-chain amino acids.

15 BkdR likely responds to the presence of branched-chain amino acids.

16 ently by altering the intracellular level of branched-chain amino acids.

17 nd sugars, and the genes for biosynthesis of branched-chain amino acids.

18 e availability of key nutrients like GTP and branched-chain amino acids.

19 , an essential enzyme in the biosynthesis of branched-chain amino acids.

20 by AMP deaminase 3 (Ampd3) and catabolism of branched-chain amino acids.

21 alyses the first step in the biosynthesis of branched-chain amino acids(1).

22 rved between patients who received high-dose branched-chain amino acids (222 mg/kg of body weight t.i

23 ncies and growth restriction associated with branched-chain amino acid accumulation and (ii) energy d

24 assic maple syrup urine disease pups reduced branched-chain amino acid accumulation in milk as well a

25 o repress transcription, suggesting that the branched-chain amino acids act as inducers rather than c

26 Changes in branched-chain amino acids after MI were associated with

27 istently higher content of free amino acids (branched-chain amino acids, alanine, serine, glycine, pr

28 sult from alanine aminotransferase (ALT) and branched-chain amino acid aminotransferase (BcAT)'s high

29 (E. coli aspartate aminotransferase, E. coli branched-chain amino acid aminotransferase, and Bacillus

30 -well plate spectrophotometric assay for the branched-chain amino acid aminotransferases is described

31 In addition, (1)H MRS showed an increase in branched chain amino acid and alanine concentrations.

32 acid metabolism were evident from increased branched chain amino acid and asparagine levels and alte

33 ), and enrichment in metabolic pathways (eg, branched chain amino acids and arginine biosynthesis) an

34 r metabolite biomarkers of diabetes, such as branched chain amino acids and aromatic amino acids, sug

35 S. aureus CodY was activated in vitro by the branched chain amino acids and GTP, CodY appears to link

36 and proteins, including ones in pathways of branched-chain amino acid and fatty acid metabolism and

37 ystal structure of the GAF domain of CodY, a branched-chain amino acid and GTP-responsive regulator o

38 Here, we highlight collaboration in branched-chain amino acid and pantothenate (vitamin B5)

39 olutionary age analysis revealed that, while branched-chain amino acid and proline catabolism are ver

40 cumulation as well as circulating cytokines, branched-chain amino acids and acylcarnitines in the pat

41 Circulating branched-chain amino acids and aromatic amino acids were

42 e with low FENO, had higher levels of plasma branched-chain amino acids and bile acids.

43 tion, we prepared a series of 11 fluorinated branched-chain amino acids and evaluated them and their

44 to MS, we detected significant increases in branched-chain amino acids and intermediates of arginine

45 abolism, ETHE1 also affects the oxidation of branched-chain amino acids and lysine.

46 resulting in accumulation of fatty acids and branched-chain amino acids and oncogenic mTOR activation

47 For example, branched-chain amino acids and proline, required for col

48 Binding studies with branched-chain amino acids and their analogs revealed th

49 n family are involved in the biosynthesis of branched-chain amino acids and/or in the Met chain elong

50 ysophosphatidylethanolamines, 5 ceramides, 3 branched chain amino acids, and 9 neurotransmitters).

51 Ceramides, lysolipids, aromatic amino acids, branched chain amino acids, and stress-induced amino aci

52 etic performance in this group are creatine, branched-chain amino acid, and beta-hydryoxy-beta-methyl

53 thesized that protein, essential amino acid, branched-chain amino acid, and leucine intakes are assoc

54 and the catabolism of odd-chain fatty acids, branched-chain amino acids, and cholesterol.

55 -density lipoprotein lipids, glucose levels, branched-chain amino acids, and inflammatory markers.

56 luding diacylglycerols and triacylglycerols, branched-chain amino acids, and markers reflecting metab

57 Branched chain amino acids are particularly effective in

58 s subtilis operon (ilvB) for biosynthesis of branched-chain amino acids are subject to multiple mecha

59 sted the effects of a genetic determinant of branched-chain amino acid/aromatic amino acid ratio on c

60 We genotyped the branched-chain amino acid/aromatic amino acid ratio-asso

61 Individuals carrying the C allele of the branched-chain amino acid/aromatic amino acid ratio-asso

62 e-dependent decarboxylating enzyme that uses branched-chain amino acids as substrate.

63 holipids and amino acids (Trp, Met, and Cys, branched-chain amino acids), as well as carnitine shuttl

64 nvolved with biosynthesis and degradation of branched-chain amino acids, as well as in the production

65 eases, indicating a coordinate regulation of branched-chain amino acids at a post-mRNA level.

66 convergence of microRNAs and TFs within the branched chain amino acid (BCAA) metabolic pathway, poss

67 electrophoresis (MD-CE) assay for monitoring branched chain amino acid (BCAA) uptake/release dynamics

68 Lung tumors catabolize circulating branched chain amino acids (BCAA) to extract nitrogen fo

69 rsity includes: inflammation, degradation of branched chain amino acids (BCAA), and regulation of per

70 ta are currently available on the effects of branched-chain amino acid (BCAA) and branched-chain keto

71 CodY is a branched-chain amino acid (BCAA) and GTP sensor and a gl

72 synthase (AHAS) catalyzes the first step of branched-chain amino acid (BCAA) biosynthesis, a pathway

73 cetohydroxyacid synthase (AHAS) required for branched-chain amino acid (BCAA) biosynthesis.

74 three Bacillus subtilis operons involved in branched-chain amino acid (BCAA) biosynthesis.

75 e (BCKDH) catalyzes the critical step in the branched-chain amino acid (BCAA) catabolic pathway and h

76 We previously described abnormalities in the branched-chain amino acid (BCAA) catabolic pathway as a

77 Branched-chain amino acid (BCAA) catabolism is regulated

78 ways involved in inflammation, fibrosis, and branched-chain amino acid (BCAA) catabolism; systemic ma

79 augment BCKDC flux have been shown to reduce branched-chain amino acid (BCAA) concentrations in vivo.

80 enylbutyrate administration decreases plasma branched-chain amino acid (BCAA) concentrations, and pre

81 associated with reduced or borderline plasma branched-chain amino acid (BCAA) concentrations.

82 d correlations among metabolites involved in branched-chain amino acid (BCAA) degradation, trimethyla

83 Branched-chain amino acid (BCAA) metabolism plays a cent

84 ogenase (BCKDH) complex, a core component of branched-chain amino acid (BCAA) metabolism.

85 production, while it does not contribute to branched-chain amino acid (BCAA)-derived aldehyde biosyn

86 ing utilization of free fatty acid (FFA) and branched-chain amino acid (BCAA).

87 Branched-chain amino acid (BCAA; valine, leucine and iso

88 posed cells are either supplemented with the branched-chain amino acids (BCAA) anaerobically or retur

89 its and enzymes involved in the oxidation of branched-chain amino acids (BCAA) and fatty acids (e.g.,

90 The branched-chain amino acids (BCAA) are essential amino ac

91 ldup of branched-chain keto-acids (BCKA) and branched-chain amino acids (BCAA) in body fluids (e.g. k

92 een associated with a selective reduction in branched-chain amino acids (BCAA) in spite of adequate d

93 does not grow in minimal medium lacking the branched-chain amino acids (BCAA) leucine or valine but

94 duced muscle expression of genes involved in branched-chain amino acids (BCAA) metabolism.

95 are enzymes that initiate the catabolism of branched-chain amino acids (BCAA), such as leucine, ther

96 orphology and higher levels of ketogenic and branched-chain amino acids (BCAA).

97 Branched chain amino acids (BCAAs) are building blocks f

98 fat, or high-fat diet supplemented with 1.5X branched chain amino acids (BCAAs) by replacing carbohyd

99 ith varying doses of leucine or a mixture of branched chain amino acids (BCAAs) on myofibrillar prote

100 Branched chain amino acids (BCAAs) play critical roles i

101 High-protein diets, rich in methionine and branched chain amino acids (BCAAs), apparently reduce li

102 reductions were seen in the concentration of branched chain amino acids (BCAAs), which are key precur

103 tissue can metabolize substantial amounts of branched chain amino acids (BCAAs).

104 Evidence suggests a role for impaired branched-chain amino acid (BCAAs; isoleucine, leucine, v

105 -1.kg-1.180 min; P = 0.04; eta2p = 0.31] and branched-chain amino acids (BCAAs) [between-group differ

106 esized that a greater decline in circulating branched-chain amino acids (BCAAs) after weight loss ind

107 Circulating amino acids, such as branched-chain amino acids (BCAAs) and aromatic amino ac

108 Circulating branched-chain amino acids (BCAAs) and aromatic amino ac

109 emonstrated, while it is yet unclear whether branched-chain amino acids (BCAAs) are a primary input o

110 We find that elevated plasma levels of branched-chain amino acids (BCAAs) are associated with a

111 tudies have shown that increased circulating branched-chain amino acids (BCAAs) are associated with i

112 Recent studies have shown that circulating branched-chain amino acids (BCAAs) are elevated in obese

113 Branched-chain amino acids (BCAAs) are synthesized in pl

114 Branched-chain amino acids (BCAAs) are three of the nine

115 The branched-chain amino acids (BCAAs) are vital to both gro

116 Circulating branched-chain amino acids (BCAAs) associate with insuli

117 mportant for acid adaptation, as turnover of branched-chain amino acids (bcAAs) could provide importa

118 the same initiating events, these tumors use branched-chain amino acids (BCAAs) differently.

119 The branched-chain amino acids (BCAAs) Ile, Val, and Leu are

120 demiological and experimental data implicate branched-chain amino acids (BCAAs) in the development of

121 have previously shown that the limitation of branched-chain amino acids (BCAAs) is a cue that induces

122 the pools of specific metabolites, i.e., the branched-chain amino acids (BCAAs) isoleucine, leucine,

123 The branched-chain amino acids (BCAAs) Leu, Ile, and Val are

124 Complete oxidation of the branched-chain amino acids (BCAAs) leucine, isoleucine (

125 The branched-chain amino acids (BCAAs) leucine, isoleucine,

126 Based on evidence that dysregulation of branched-chain amino acids (BCAAs) may contribute to the

127 Altered branched-chain amino acids (BCAAs) metabolism is a disti

128 In the brain, catabolism of the branched-chain amino acids (BCAAs) provides nitrogen for

129 That is, branched-chain amino acids (BCAAs) served as more potent

130 The branched-chain amino acids (BCAAs) valine, leucine and i

131 bs (n = 24) were enterally supplemented with branched-chain amino acids (BCAAs), carbohydrate (maltod

132 Therefore, the branched-chain amino acids (BCAAs), especially leucine,

133 Dietary supplementation with branched-chain amino acids (BCAAs), including leucine, i

134 that BCAT1, a cytosolic aminotransferase for branched-chain amino acids (BCAAs), is aberrantly activa

135 Branched-chain amino acids (BCAAs), particularly leucine

136 A preceded by reduced amino acid proline and branched-chain amino acids (BCAAs), respectively.

137 ed in the oxidation of fatty acids (FAs) and branched-chain amino acids (BCAAs), senses nutrients and

138 ccompanied by elevated circulating levels of branched-chain amino acids (BCAAs), whereas both paramet

139 g healthy mice a diet with reduced levels of branched-chain amino acids (BCAAs), which are associated

140 the enzyme that initiates the catabolism of branched-chain amino acids (BCAAs).

141 alpha-keto acids (BCKAs) are catabolites of branched-chain amino acids (BCAAs).

142 interaction with its effectors, GTP and the branched-chain amino acids (BCAAs).

143 Branched-chain amino acids (BCAAs, i.e., valine, leucine

144 Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leu

145 Branched-chain amino acids (BCAAs; leucine, isoleucine a

146 Branched-chained amino acids (BCAAs) (Leu, Ile, and Val)

147 insulin were to reduce plasma levels of the branched chain amino acids (BCAs) leucine/isoleucine and

148 t differences in the amounts of aromatic and branched chain amino acids between the groups as well as

149 ed a significant difference in the levels of branched-chain amino acids between the wild type and Del

150 SBPs, which had been previously annotated as branched-chain amino-acid-binding proteins.

151 onal yeast mitochondrial enzyme required for branched chain amino acid biosynthesis and for the stabi

152 For example, Ilv5 is required for branched chain amino acid biosynthesis and mtDNA stabili

153 The mathematical model of branched chain amino acid biosynthesis in E. coli K12 pr

154 ein in Saccharomyces cerevisiae required for branched-chain amino acid biosynthesis and for the stabi

155 halts bacterial growth via inhibition of the branched-chain amino acid biosynthesis enzyme dihydroxya

156 and raised the root and shoot levels of the branched-chain amino acid biosynthesis intermediate 2-ox

157 cid synthase (AHAS), the first enzyme in the branched-chain amino acid biosynthesis pathway.

158 . 2.2.1.6), which is the first enzyme in the branched-chain amino acid biosynthesis pathway.

159 l was based, demonstrated the involvement of branched-chain amino acid biosynthesis, ascorbate and al

160 ctively catalyze the first committed step of branched-chain amino acid biosynthesis, but ilvG is uniq

161 A-B27-negative AAU, including an increase of branched-chain amino acid biosynthesis, that reflects di

162 ains lacking a YjgF homolog have a defect in branched-chain amino acid biosynthesis.

163 yme reactions and regulatory circuits of the branched chain amino acid biosynthetic pathways, includi

164 pA have been shown to regulate expression of branched-chain amino acid biosynthetic genes, suggesting

165 2 skeletal muscle had increased oxidation of branched chain amino acids but decreased oxidation of fa

166 ues essential for full activation of CodY by branched-chain amino acids, but these residues are not c

167 These data led to the discovery of impaired branched chain amino acid catabolic enzyme isovaleryl-Co

168 ylase, and 3-methylcrotonyl-CoA carboxylase (branched chain amino acids catabolism).

169 by metformin exposure, including changes in branched-chain amino acid catabolism and cuticle mainten

170 Collectively, these results indicate that branched-chain amino acid catabolism contributes to TAG

171 yl-CoA (HMG-CoA) lyase (HMGL) is involved in branched-chain amino acid catabolism leading to acetyl-C

172 hat several Arabidopsis mutants deficient in branched-chain amino acid catabolism or fatty acid metab

173 It also increases our knowledge of the role branched-chain amino acid catabolism plays in seed devel

174 Increased plasma branched-chain amino acid concentrations are associated

175 Branched-chain amino acids constitute a novel, safe trea

176 The branched-chain amino acids, creatine, lysine, 2-aminobut

177 the identification and characterization of a branched-chain amino acid decarboxylase, which would app

178 detection of the major CoA-intermediates of branched chain amino acid degradation in biological samp

179 c pathways such as the citric acid cycle and branched chain amino acid degradation.

180 rior to this study, the relationship between branched-chain amino acid degradation (named for leucine

181 Furthermore, the Hadza GM is equipped for branched-chain amino acid degradation and aromatic amino

182 oteins: the H-protein and the E2 subunits of branched chain amino acid dehydrogenase (BCDH) and alpha

183 The metabolite 3-MOB along with related branched-chain amino acids demonstrated strong predictab

184 amino acids for colonization, acquisition of branched-chain amino acids does not appear to be a deter

185 that C. difficile preferentially catabolizes branched chain amino acids during CDI.

186 tend beyond a role for binding and acquiring branched-chain amino acids during commensalism.

187 r very-low-density lipoprotein measures, and branched-chain amino acids (e.g., leucine OR = 2.94, 2.5

188 erprints of severe obesity were aromatic and branched-chain amino acids (elevated), metabolites relat

189 a 10 gene cluster responsible for increased branched chain amino acid fermentation in the co-culture

190 d redirect metabolism for the utilization of branched-chain amino acids for energy, carbon, and perha

191 sted that Ca. C. thermophilum may synthesize branched-chain amino acids from an intermediate(s) of th

192 lude testosterone analogues, growth hormone, branched chain amino acid, glutamine, arginine, creatine

193 le genome-wide association studies (GWAS) on branched-chain amino acids have identified some regulato

194 The catabolic pathways of branched-chain amino acids have two common steps.

195 ys an important role in regulating levels of branched chain amino acids in seeds.

196 lysis revealed a defect in the catabolism of branched-chain amino acids in bkdE1alpha Furthermore, th

197 d to increased circulating concentrations of branched-chain amino acids in fasting.

198 reported to confer transport of proline and branched-chain amino acids in in vitro expression system

199 und reduced concentrations of vitamin B6 and branched-chain amino acids in PSC (P < .0001), which str

200 confirm an important role for catabolism of branched-chain amino acids in T2D and IFG.

201 genotype and diet, with a unique increase in branched-chain amino acids in the Glyco(Hi) HFD group.

202 f the authors, that focus on the role of the branched-chain amino acids in the regulation of mRNA tra

203 The efficacy of the branched-chain amino acids in the treatment of tardive d

204 to GTP in vitro but also responded poorly to branched-chain amino acids in vitro unless GTP was simul

205 atable by GTP but to a much lesser extent by branched-chain amino acids in vitro.

206 yme inhibitors and the rich concentration of branched-chain amino acids in whey, which act synergisti

207 The catabolic pathway for branched-chain amino acids includes deamination followed

208 Because mammals do not synthesize branched-chain amino acids, inhibition of dihydroxyacid

209 zyme's substrate and stereospecificity for L-branched chain amino acids is a group of hydrophobic res

210 Accumulation of free isoleucine and other branched-chain amino acids is greatly elevated in respon

211 hypothesis that raised plasma levels of the branched-chain amino acids isoleucine, leucine, and vali

212 reased in presymptomatic HD sheep, including branched chain amino acids (isoleucine, leucine and vali

213 l transcriptional regulator that responds to branched-chain amino acids (isoleucine, leucine, and val

214 metabolic precursors (i.e., fatty acids and branched-chain amino acids), isotope labeling analyses s

215 ficits in enzymes required for catabolism of branched chain amino acids, ketones, and lactate, along

216 gulated pathways for the biosynthesis of the branched chain amino acids L-isoleucine, L-valine, and L

217 Branched-chain amino acids L-isoleucine, L-leucine, and

218 ave been the subject of great scrutiny, as a branched-chain amino acid, Leu can be catabolized within

219 l amino acid phenylalanine and the essential branched chain amino acids leucine, isoleucine, and vali

220 The branched chain amino acids leucine, isoleucine, valine,

221 The branched-chain amino acid leucine is an essential nutrie

222 the ability of nutrients, in particular the branched-chain amino acid leucine, to activate mTOR inde

223 The branched-chain amino acids leucine and isoleucine lower

224 icantly raised the circulating levels of the branched-chain amino acids leucine, isoleucine, and vali

225 Branched chain amino acids (leucine, isoleucine and vali

226 4.1, 95% CI [-7.0; -1.1], p = 0.007) and the branched-chain amino acids (leucine: beta = -6.0, 95% CI

227 e disease (MSUD) is an inherited disorder of branched chain amino acid metabolism presenting with neo

228 ter has an in vivo role in the regulation of branched chain amino acid metabolism.

229 F1F0-ATPase system, fatty acid biosynthesis, branched chain amino acids metabolism), and molecular ch

230 Major metabolic pathways were branched-chain amino acid metabolism (partially independ

231 pts surrounding the current understanding of branched-chain amino acid metabolism and its role in can

232 Adiponectin corrected the altered branched-chain amino acid metabolism caused by HFD and c

233 The subcellular sites of branched-chain amino acid metabolism in plants have been

234 e disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism presenting with lif

235 nning on page 434) defined a new disorder of branched-chain amino acid metabolism resembling human ma

236 deregulated in many cancers, with changes in branched-chain amino acid metabolism specifically affect

237 spiration, an ornithine-glutamine shunt, and branched-chain amino acid metabolism were hypothesized a

238 zed the condensation of two intermediates in branched-chain amino acid metabolism, isovaleryl-Coenzym

239 tion of proteins in fatty acid oxidation and branched-chain amino acid metabolism.

240 e A (CoA) transfer to isoleucine and reduced branched-chain amino acid metabolism.

241 influenced starch and sucrose, nitrogen, and branched-chain amino acids metabolism pathways.

242 ex and formation of a metabolic unit (termed branched-chain amino acid metabolon) that can be influen

243 ained before and 7 hours after a single oral branched chain amino acid mixture enriched with leucine

244 nsulin resulted in increased plasma glucose, branched chain amino acids, nonesterified fatty acids, b

245 Neither essential amino acids, branched-chain amino acids, nor any individual amino aci

246 dyskinesia were randomly assigned to receive branched-chain amino acids or placebo.

247 ociated with multiple metabolites, including branched-chain amino acids, other hydrophobic amino acid

248 of the BCKDC, promotes metabolon formation, branched-chain amino acid oxidation, and cycling of nitr

249 ehydrogenase (PDH) as well as fatty acid and branched-chain amino acid oxidation.

250 arget of rapamycin (mTOR), through which the branched-chain amino acids, particularly leucine, act to

251 The branched-chain amino acid pathways are extended to produ

252 he general amino acid permease (Aap) and the branched-chain amino acid permease (Bra) of Rhizobium le

253 solute transport systems: PA1971 (braZ) for branched-chain amino acids permease; PA2042 for a putati

254 t-chain dicarboxylacylcarnitines (SCDA), and branched-chain amino acid plasma biomarkers were indepen

255 er biochemical inhibition of biosynthesis of branched-chain amino acids (precursors to branched-chain

256 CodY is a branched-chain amino acid-responsive transcriptional reg

257 The addition of branched-chain amino acids restored growth, indicating t

258 es of cardiovascular disease risk (including branched-chain amino acids, select unsaturated lipid spe

259 Branched-chain amino acids, such as leucine and glucose,

260 gion was enhanced in the presence of GTP and branched-chain amino acids, suggesting a link between nu

261 Branched-chain amino acids supplement may be helpful in

262 Branched chain amino acid supplements may be of value in

263 th microbial function; 13 pathways including branched chain amino acid synthesis were significantly e

264 of genes related to vitamin B6 synthesis and branched-chain amino acid synthesis (Q(fdr) < .05).

265 ctional gene classes, including aromatic and branched-chain amino acid synthesis, ribosomal proteins,

266 ing dihydroxyacid dehydratase, important for branched-chain amino acid synthesis.

267 talyses the transfer of the amino group from branched-chain amino acids to alpha-ketoglutarate (alpha

268 e-long dietary restriction and monitoring of branched-chain amino acids to avoid brain injury.

269 IDH1 mutation and decreased activity of the branched-chain amino acid transaminase 1 (BCAT1) enzyme.

270 how that glioblastoma express high levels of branched-chain amino acid transaminase 1 (BCAT1), the en

271 on of its direct targets including the BCAT2 branched-chain amino acid transaminase 2) gene.

272 s well as single-nucleotide polymorphisms in branched-chain amino-acid transaminase 1 (BCAT1) and phe

273 ic glucosinolate biosynthesis in tandem with BRANCHED-CHAIN AMINO ACID TRANSAMINASE4, which is involv

274 was identified as a potential biomarker for branched chain amino acid transferase inhibitor activity

275 scovered a potential causal link between the branched-chain amino acid transferase BCAT-1 and the neu

276 uced miR-276-5p fine-tunes the expression of branched-chain amino acid transferase to terminate the r

277 n with a chromosomal interval containing two branched-chain amino acid transferases, BCAT1 and BCAT2.

278 of the leucine, isoleucine, and valine (LIV) branched-chain amino acid transport system, reduced the

279 Despite each LIV protein being required for branched-chain amino acid transport, only the LivJ and L

280 ase in acetate, lactate, succinate, alanine, branched chain amino acids, trimethylamine and a progres

281 t-activity rhythm) and metabolic parameters (branched-chain amino acids, tryptophan pathway, phenylal

282 ultivariate analyses identified preoperative branched-chain amino acid/tyrosine ratio (BTR) <5, alani

283 howed severe disturbance in the synthesis of branched-chain amino acids upon treatment with imazapyr.

284 Reduced branched-chain amino acid uptake and increased accumulat

285 Concentrations of the branched-chain amino acids valine, isoleucine, and leuci

286 Products from the degradation of the branched-chain amino acids valine, leucine, and isoleuci

287 abolic disorder, affecting the metabolism of branched chain amino-acids (Valine, Leukine, Isoleukine)

288 Genes for the synthesis of branched-chain amino acids (valine, isoleucine and leuci

289 posure to PFAS and increased serum levels of branched-chain amino acids (valine, leucine, and isoleuc

290 We radiofluorinated selected branched-chain amino acids via the same radical fluorina

291 Accumulation of the branched-chain amino acids was accompanied by a 24-fold

292 g to the intracellular levels of GTP and the branched-chain amino acids, was previously shown to be a

293 of CodY with various levels of activation by branched-chain amino acids, we concluded that unliganded

294 By altering the availability of branched-chain amino acids, we further demonstrated CodY

295 Prominent changes in branched-chain amino acids were observed after 1 week of

296 i produced leucine, isoleucine and valine as branched chain amino acids when grown on LBG hydrolysate

297 coneogenesis and oxidations of glutamine and branched chain amino acids, which together sustain the n

298 Leucine (Leu) is an essential branched-chain amino acid, which activates the mammalian

299 Metformin reduced levels of circulating branched-chain amino acids, which regulate tryptophan up

300 BCAT1 catalyzes the transamination of branched-chain amino acids while converting alpha-ketogl